The COVID-19 pandemic has necessitated rapid digitization of everyday activities across the world, and the clinical research industry is no exception. Adopting decentralized methods in this space is not an option; it’s now a requirement for normal operations.
In this white paper, we discuss how with use of appropriate decentralized technology participants can engage in research from the comfort of their own homes.
Download this white paper to learn the following:
- Steps research organizations are taking to decentralize aspects of their trials
- Legal and regulatory considerations for using remote research methods
- Mistakes to avoid when constructing or converting to a decentralized model
- Key considerations for choosing a decentralized software vendor